AGREEMENT FOR THE PROVISION OF A LOAN FACILITY OF UP TO €18,000,000 Dated 27th August 2019 BetweenLoan Agreement • August 5th, 2020 • Orphazyme a/S • Pharmaceutical preparations • England
Contract Type FiledAugust 5th, 2020 Company Industry JurisdictionKREOS CAPITAL VI (UK) LIMITED, a company incorporated in England and Wales under registration number 11535385 whose registered office is at Amf Building, 25 Old Burlington Street, London W1S 3AN (the "Lender", which expression shall include its successors and assigns);
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 5th, 2020 • Orphazyme a/S • Pharmaceutical preparations
Contract Type FiledAugust 5th, 2020 Company IndustryThis Asset Purchase Agreement (this “Agreement”) is made as of May 13, 2011, by and between CytRx Corporation, a Delaware corporation (“Seller”), and Orphazyme ApS, a company organized under the laws of Denmark (“Buyer”). Seller and Buyer are each referred to individually as a “Party” and collectively as the “Parties.”